CSPC Pharmaceuticals Group Ltd. revenue for the last year amounted to 4.43 B USD, the most of which — 3.63 B USD — came from its highest performing source at the moment, Finished Drugs, the year earlier bringing 3.14 B USD. The greatest contribution to the revenue figure was made by China — last year it brought CSPC Pharmaceuticals Group Ltd. 3.85 B USD, and the year before that — 3.35 B USD.